Standard outcome indicators after colon cancer resection. Creation of a nomogram for autoevaluation
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Ramos Rodriguez JL
- Romero Simó M
- Escoll Rufino J
- Santamaría Olabarrieta M
- Viñas Martinez J
- López Bañeres M
- ANACO Study Group
Grupos
Abstract
Introduction: Lately there has been an increasing interest in identifying quality standards in different pathologies, among them colon cancer due to its great prevalence. The main goal of this study is to define the quality standards of colon cancer surgery based on a large prospective national study dataset. Methods: Data from the prospective national study ANACO were used. This study included a consecutive series of patients operated on for colon cancer in 52 Spanish hospitals (20112012). Centers with less than 30 patients were excluded. The present analysis finally included 42 centers (2975 patients). Based on the results obtained in 4 main indicators from each hospital (anastomotic leak, lymph-nodes found in the specimen, mortality and length of stay), a nomogram that allows the evaluation of the performance of each center was designed. Standard results for further 5 intraoperative and 5 postoperative quality indicators were also reported. Results: Median of anastomotic leak and mortality rate was 8.5% (25th-75th percentiles 6.1%12.4%) and 2.5% (25th-75th percentiles 0.6%-4.7%), respectively. Median number of nodes found in the surgical specimen was 15,1 (25th-75th percentiles 18-14 nodes). Median length of postoperative stay was 7.7 days (25th-75th percentiles 6.9-9.2 days). Based on these data, a nomogram for hospital audit was created. Conclusions: Standard surgical results after colon cancer surgery were defined, creating a tool for auto-evaluation and allowing each center to identify areas for improvement in the surgical treatment of colon cancer. (C)2016 AEC. Published by Elsevier Espana, S.L.U. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0009-739X, 1578-147X
- Tipo:
- Article
- Páginas:
- 30-37
- Factor de Impacto:
- 0,249 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
CIRUGIA ESPANOLA ELSEVIER DOYMA SL
Citas Recibidas en Web of Science: 11
Documentos
- No hay documentos
Filiaciones
Keywords
- Colonic neoplasms; Colon surgery; Outcome assessment; Quality indicators; Reference standards
Proyectos asociados
IDENTIFICACION DE NUEVAS MOLECULAS CON ACTIVIDAD ANTICOAGULANTE Y/O CITOPROTECTORA EN LA VIA DE LA PROTEINA C: EXPLORANDO SU UTILIDAD CLINICA.
Investigador Principal: SILVIA NAVARRO ROSALES
PI14/00512 . INSTITUTO DE SALUD CARLOS III . 2015
WIBEC. WIRELESS IN-BODY ENVIRONMENT COMMUNICATIONS.
Investigador Principal: VICENTE PONS BELTRÁN
675353 . COMISION EUROPEA . 2016
IMPLANTACIÓN DE LA MEDICINA PERSONALIZADA EN ONCOLOGÍA PEDIÁTRICA: FARMACOGENÉTICA, EPIGENÉTICA, METABOLÓMICA Y LOS SISTEMAS DE INFORMACIÓN.
Investigador Principal: MARÍA JOSÉ HERRERO CERVERA
MJH-CIS-2016-01 . FUNDACION MUTUA MADRILEÑA . 2016
CARACTERIZACIÓN EPIGENÓMICA DE LA ANOREXIA NERVIOSA. MODELO DE GEMELAS MONOCIGOTAS DISCORDANTES Y VALIDACIÓN EN POBLACIÓN GENERAL.
Investigador Principal: LUIS MIGUEL ROJO MORENO
PI16/01279 . INSTITUTO DE SALUD CARLOS III . 2017
VALIDACIÓN/IDENTIFICACIÓN DE BIOMARCADORES EPIGENÓMICOS PARA DIAGNOSTICO PRECOZ Y RESPUESTA A FÁRMACO PARA MEJORAR EL MALA EVOLUCIÓN DE PACIENTES CON CÁNCER DE PULMÓN CÉLULA NO PEQUEÑA.
Investigador Principal: JUAN SANDOVAL DEL AMOR
PI16/00295 . INSTITUTO DE SALUD CARLOS III . 2017
PRESIÓN INDIVIDUALIZADA DE INSUFLACIÓN DEL PNEUMOPERITONEO EN CIRUGÍA LAPAROSCÓPICA COLORECTAL FRENTE A TERAPIA ESTÁNDAR.
Investigador Principal: ÓSCAR DÍAZ CAMBRONERO
IPPCOLLAPSE-II . 2016
ESTUDIO ALEATORIZADO MULTICÉNTRICO EN FASE III DE RADIOTERAPIA DE CORTA DURACIÓN SEGUIDA DE QUIMIOTERAPIA PREOPERATORIA DE LARGA DURACIÓN Y CIRUGÍA EN EL CÁNCER RECTAL PRIMARIO DE ALTO RIESGO EN COMPARACIÓN CON QUIMIORRADIOTERAPIA CONVENCIONAL Y CIRUGÍA Y OPTIMA QUIMIOTERAPIA ADYUVANTE.
Investigador Principal: JORGE APARICIO URTASUN
RAPIDO
ENSAYO CLÍNICO MULTICÉNTRICO ALEATORIZADO EN PACIENTES CON CÁNCER COLO-RECTAL CON METÁSTASIS IRRESECABLES. IMPACTO DE LA RESECCIÓN TUMORAL VS QUIMIOTERAPIA SOLA SOBRE LA SUPERVIVENCIA.
Investigador Principal: FRANCISCO JAVIER VAQUE URBANEJA
01CCRE-IV
Cita
Sancho J,Frasson M,Hervas D,Flor B,Ramos JL,Romero M,Escoll J,Santamaría M,Viñas J,López M,Garcia E,ANACO G. Standard outcome indicators after colon cancer resection. Creation of a nomogram for autoevaluation. Cir Esp (Engl Ed). 2017. 95. (1):p. 30-37. IF:0,841. (4).